Prevalence of diabetes in France and drug use: Study based on the french pharmacovigilance database

被引：4

作者：

Berthet, Stephanie ^{[1
]}

Grolleau, Sabrina ^{[1
]}

Brefel-Courbon, Christine ^{[2
]}

Montastruc, Jean-Louis ^{[1
,2
]}

Lapeyre-Mestre, Maryse ^{[1
,2
]}

机构：

[1] Univ Toulouse 3, Fac Med, Unite Pharmacoepidemiol, EA 3696, F-31062 Toulouse, France

[2] Fac Med Toulouse, Serv Pharmacol Clin, Toulouse, France

来源：

THERAPIE | 2007年 / 62卷 / 06期

关键词：

diabetes; pharmacovigilance database; hypoglycemiant drugs; prevalence; claims database;

D O I：

10.2515/therapie:2007076

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Aim: The aim of this study was to investigate the use of the French Pharmacovigilance Database to estimate characteristics of drug utilization in specific diseases. Materials and method: We identified diabetic patients from the French Pharmacovigilance Database between 2002 and 2005. In this population, we studied demographic characteristics, and the patterns of drug use, particularly hypoglycemiant drug use and other drug exposure. In order to validate this approach, we compared our data to a population of patients with diabetes identified from the French Health Insurance System claims database in one French area. Results: The estimation of prevalence of diabetes was very close in the sources: 2.7% in the French Pharmacovigilance Database and 3.2% in the French Health Insurance System claims database. We found similar results as well for demographic characteristics as for hypoglycemiant drug use and other drug exposure. Conclusion: These results suggest that the French Pharmacovigi lance Database may be used to investigate drug utilization patterns.

引用

页码：483 / 488

页数：6

共 19 条

[1]

*AG NAT ACCR EV SA, 2003, PRINC DEP DIAB TYP 2

[2] Rates of spontaneous reporting of adverse drug reactions in France [J].

Bégaud, B ;

Martin, K ;

Haramburu, F ;

Moore, N .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (13) :1588-1588

[3]

*BEH, 49502003 BEH

[4] Attitude survey of adverse drug-reaction reporting by health care professionals across the European Union [J].

Belton, KJ ;

Gram, LF ;

Royer, RJ ;

Feely, J ;

McGettigan, P ;

Velo, GP ;

Conforti, A ;

Leone, R ;

Stricker, BHC ;

Teixeira, F ;

Laporte, JP ;

Capella, D ;

Beermann, B ;

Lewis, SC ;

Payne, S ;

Rawlins, MD ;

Wood, SM .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 52 (06) :423-427

[5] Under-prescribing of cardiovascular therapies for diabetes in primary care [J].

Bennett, KE ;

Williams, D ;

Feely, J .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 58 (12) :835-841

[6]

Berthet S, 2007, FUND CLIN PHARMACOL, V21, P11

[7]

Brefel-Courbon C, 2007, FUND CLIN PHARMACOL, V21, P10

[8]

FAGOTCAMPAGNA A, PRINCIPAUX RESULTATS

[9]

Fender P, 1997, REV EPIDEMIOL SANTE, V45, P454

[10]

FONTBONNE A, 1986, REV EPIDEMIOL SANTE, V34, P100

← 1 2 →